Caris Life Sciences, Inc.
CAINasdaqCIK 2019410HealthcareFiscal year ends Dec 31
Reports and events: 20 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1416:38 ET | 8-K | 7.01 Regulation FD disclosure | 0002019410-26-000061 |
| 2026-08-0517:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0002019410-26-000055 |
| 2026-08-0516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-26-000053 |
| 2026-06-0517:03 ET | 8-K | 5.07 Shareholder vote results | 0002019410-26-000046 |
| 2026-05-0816:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0002019410-26-000044 |
| 2026-05-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-26-000040 |
| 2026-04-2306:23 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0002019410-26-000032 |
| 2026-04-0216:28 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0002019410-26-000019 |
| 2026-03-0316:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0002019410-26-000016 |
| 2026-02-2616:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002019410-26-000011 |
| 2026-01-1209:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002019410-26-000005 |
| 2025-11-0517:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0002019410-25-000028 |
| 2025-11-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-25-000026 |
| 2025-10-3016:20 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0002019410-25-000020 |
| 2025-08-1216:59 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0002019410-25-000012 |
| 2025-08-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002019410-25-000011 |
| 2025-06-2016:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061148 |
| 2025-06-1607:01 ET | S-1/A | Registration statement, amended | 0001104659-25-059635 |
| 2025-06-0907:05 ET | S-1/A | Registration statement, amended | 0001104659-25-057593 |
| 2025-05-2315:27 ET | S-1 | Registration statement | 0001104659-25-052381 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.